125 related articles for article (PubMed ID: 1303908)
21. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
Dinger J; Töpfer A; Schaller P; Schwarze R
Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
[TBL] [Abstract][Full Text] [Related]
22. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group.
Herting E; Gefeller O; Land M; van Sonderen L; Harms K; Robertson B
Pediatrics; 2000 Nov; 106(5):957-64; discussion 1135. PubMed ID: 11061760
[TBL] [Abstract][Full Text] [Related]
23. Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant.
van Zyl JM; Smith J
Drug Des Devel Ther; 2013; 7():905-16. PubMed ID: 24039400
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Collaborative European Multicentre Study Group.
Eur J Pediatr; 1991 Apr; 150(6):433-9. PubMed ID: 2040354
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of severe respiratory distress syndrome with surfactant].
Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
[TBL] [Abstract][Full Text] [Related]
26. Surfactant treatment in the neonate with severe respiratory distress syndrome.
Horpaopan S; Sangtaveesin V; Ratrisawasdi V
J Med Assoc Thai; 1996 Apr; 79(4):222-8. PubMed ID: 8708507
[TBL] [Abstract][Full Text] [Related]
27. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Ramanathan R; Rasmussen MR; Gerstmann DR; Finer N; Sekar K;
Am J Perinatol; 2004 Apr; 21(3):109-19. PubMed ID: 15085492
[TBL] [Abstract][Full Text] [Related]
28. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
Köksal N; Akpinar R; Cetinkaya M
Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
[TBL] [Abstract][Full Text] [Related]
29. Supraglottic Atomization of Surfactant in Spontaneously Breathing Lambs Receiving Continuous Positive Airway Pressure.
Milesi I; Tingay DG; Lavizzari A; Bianco F; Zannin E; Tagliabue P; Mosca F; Ventura ML; Rajapaksa A; Perkins EJ; Black D; Di Castri M; Sourial M; Pohlmann G; Dellaca' RL
Pediatr Crit Care Med; 2017 Sep; 18(9):e428-e434. PubMed ID: 28742723
[TBL] [Abstract][Full Text] [Related]
30. A unique story in neonatal research: the development of a porcine surfactant.
Curstedt T; Halliday HL; Speer CP
Neonatology; 2015; 107(4):321-9. PubMed ID: 26044099
[TBL] [Abstract][Full Text] [Related]
31. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
32. Comparison efficacy of Curosurf and Survanta in preterm infants with respiratory distress syndrome.
Mirzarahimi M; Barak M
Pak J Pharm Sci; 2018 Mar; 31(2):469-472. PubMed ID: 29618436
[TBL] [Abstract][Full Text] [Related]
33. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
Kukkonen AK; Virtanen M; Järvenpää AL; Pokela ML; Ikonen S; Fellman V
Acta Paediatr; 2000 May; 89(5):556-61. PubMed ID: 10852192
[TBL] [Abstract][Full Text] [Related]
35. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
Parmigiani S; Panza C; Bevilacqua G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
[TBL] [Abstract][Full Text] [Related]
36. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome.
Baraldi E; Pettenazzo A; Filippone M; Magagnin GP; Saia OS; Zacchello F
Pediatr Pulmonol; 1993 Mar; 15(3):157-62. PubMed ID: 8327278
[TBL] [Abstract][Full Text] [Related]
37. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome.
Herting E; Möller O; Schiffmann JH; Robertson B
Acta Paediatr; 2002; 91(11):1174-8. PubMed ID: 12463314
[TBL] [Abstract][Full Text] [Related]
38. Cerebral blood flow and plasma hypoxanthine in relation to surfactant treatment.
Bell AH; Skov L; Lundstrøm KE; Saugstad OD; Greisen G
Acta Paediatr; 1994 Sep; 83(9):910-4. PubMed ID: 7819684
[TBL] [Abstract][Full Text] [Related]
39. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
[TBL] [Abstract][Full Text] [Related]
40. [Intracardiac hemodynamic changes in the newborns with respiratory distress syndrome].
Perepelitsa SA; Korotkaia MV; Pavlenko OV; Golubev AM
Anesteziol Reanimatol; 2009; (1):37-40. PubMed ID: 19348326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
